Innovator & Entrepreneur in Biotechnology
Seattle, WA
Joined April 2009
- Tweets1.1K
- Following158
- Followers200
- Likes760
Christopher Pirie retweeted
(NEW EPISODE) He Raised $100 Million For A Company And Merged With Inscripta, And Is Now Converting Waste Into Valuable Products To Decarbonize The Chemicals Industry @CMPirie alejandrocremades.com/he-rai… #entrepreneur #business #success
Christopher Pirie retweeted
Awesome collaboration with the @McGuire_Lab now published! Use of @hdtbio’s LION/repRNA platform to prevent #EBV infection of humanized mice. nature.com/articles/s41541-0…
Christopher Pirie retweeted
HDT Bio recently spoke to Moira Gunn of @biotechnation to discuss the company’s progress in #RNAvaccine development and walk her through how our revolutionary repRNA/ LION™ platform works.
Listen here: bit.ly/44k4g3h
Christopher Pirie retweeted
This week on #BioTechNation, Dr. Chris Pirie, Co-Founder & COO of HDT Bio joins us to talk about their groundbreaking approaches to cancer prevention through vaccines. Listen Now: ow.ly/wTga50R6Ve2 #CancerPrevention #Vaccines
Christopher Pirie retweeted
VC Fund size to DPI plot - 168 funds covered & Vintage year 2014-2016
1. Only ~20% are in the carry
2. >$2B barely returned deployed capital back to LPs (not including fees/hurdle)
3. Median fund size of $200M returned >1.5x DPI
Will post other thematic observations later
Christopher Pirie retweeted
Today, we announced the receipt of a $749,000 EZBAA contract through a partnership with @BARDA under #ProjectNextGen’s Enabler’s program. The contract will support studies providing proof-of-concept data for our #RNA #vaccine LION™ platform and more.
prnewswire.com/news-releases…
Christopher Pirie retweeted
Our Co-founder and COO Chris Pirie, Ph.D., (@CMPirie) and five other biopharma executives spoke with @BioWorld about financial struggles the biopharma space faced this past year, and why we’re optimistic for a better 2024.
bioworld.com/media/podcasts/…
Christopher Pirie retweeted
Enabling self-amplifying RNA vaccines with @hdtbio ‘s LION formulation. More on this in my interview with @VaccineInsights insights.bio/vaccine-insight…
Christopher Pirie retweeted
BARDA is partnering w/ @hdtbio under #ProjectNextGen’s Enablers program to support proof-of-concept studies for on-demand manufacturing & release processes that use HDT Bio’s LION formulation for mRNA vaccine production. Learn more about Project NextGen: ow.ly/FvSh50Q4QM1
Christopher Pirie retweeted
The results of a recent study published in @MolTherapy suggest that in vivo administration of repRNA by LION™, HDT Bio’s technology for delivering #RNA #vaccines, is safer than other formulation technologies.
Learn more: prnewswire.com/news-releases…
Christopher Pirie retweeted
HDT Bio’s CEO and cofounder Steve Reed, Ph.D., spoke with @GinaCVitale of @cenmag as part of the cover story about cancer vaccines.
Read about the development of cancer vaccines and HDT Bio’s saRNA technology: cen.acs.org/pharmaceuticals/…
Christopher Pirie retweeted
At HDT Bio, we are proud to collaborate with organizations like @theNCI and academic institutions like @UW to investigate our self-replicating #RNA vaccine candidates for infectious disease and cancer.
Explore our research partnerships here: hdt.bio/our-partners-detail
Christopher Pirie retweeted
We’re having a great time in Boston for #BIO2023, connecting with colleagues, journalists and investors!
Learn more about HDT Bio: hdt.bio/
#BIOInternationalConvention @IAmBiotech
Christopher Pirie retweeted
NOW LIVE - BLUE KNIGHT™️ Resident QuickFire Challenge: Accelerating Project #NextGen.
Blue Knight companies & collaborators, apply for a chance to receive award funding from a total pool of $10M to help advance your science.
6/8 Info Session RSVP: jji.jnj/BK23Info
Christopher Pirie retweeted
Check out our work on evaluation of @hdtbio's self-amplifying replicon RNA (repRNA) vaccines for maternal vaccination in a pregnant rabbit model - published today in the @MolTherapy! authors.elsevier.com/a/1gobZ…
Christopher Pirie retweeted
@hdtbio and @1PACRI announce collaboration to apply HDTBio RNA tech to develop cancer vaccines and treatments for Africa to help reduce inequalities in health care. Details:
ow.ly/6Lrk50MEUov #africa #cancer #globalhealth
Christopher Pirie retweeted
@utmbhealth and @hdtbio awarded prototype project funding worth up to $87.4M from US government to develop saRNA vaccine tech. UTMB partners with HDT Bio to leverage HDT Bio saRNA vaccine platform tech and proprietary LION™ delivery system
ow.ly/eMTO50LRcIe. @jesseerasmus
Christopher Pirie retweeted
@hdtbio Steven Reed at @vaccinenation
LIVE from #WVCEU @vaccinenation @isaperena @UKHSA conclusions on her keynote panel: The #RNA revolution and how deep will it go?Collaboration, more research to be done, #pandemic #preparedness, priority list by international organisations @WHOatEU @CEPIvaccines @UKHSA #COVID19
